Is Ultragenyx Stock a Good Investment?

Ultragenyx Investment Advice

RARE

To provide specific investment advice or recommendations on Ultragenyx stock, we recommend investors consider the following general factors when evaluating Ultragenyx. This will help you to make an informed decision on whether to include Ultragenyx in one of your diversified portfolios:

Examine Ultragenyx's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Ultragenyx's leadership team and their track record. Good management can help Ultragenyx navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Biotechnology space and any emerging trends that could impact Ultragenyx's business and its evolving consumer preferences.
Compare Ultragenyx's performance and market position to its competitors. Analyze how Ultragenyx is positioned in terms of product offerings, innovation, and market share.
Check if Ultragenyx pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Ultragenyx's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Ultragenyx stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Ultragenyx is a good investment.

Sell

Buy

Strong Hold

Our trade recommendation tool can be used to complement Ultragenyx advice provided by experts. It analyzes the firm's potential to grow against your specific risk preferences and investment horizon. To make sure Ultragenyx is not overpriced, please validate all Ultragenyx fundamentals, including its book value per share, market capitalization, and the relationship between the cash per share and price to earnings to growth . Given that Ultragenyx has a price to earning of (6.90) X, we advise you to double-check Ultragenyx market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.

Market Performance	Very Weak	Details
Volatility	Very steady	Details
Hype Condition	Low key	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Low	Details
Economic Sensitivity	Follows the market closely	Details
Investor Sentiment	Alarmed	Details
Analyst Consensus	Strong Buy	Details
Financial Strenth (F Score)	Healthy	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine Ultragenyx Stock

Researching Ultragenyx's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 98.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 6.45. Ultragenyx had not issued any dividends in recent years. The entity had 1:3 split on the 17th of January 2014.

To determine if Ultragenyx is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Ultragenyx's research are outlined below:

	Ultragenyx generated a negative expected return over the last 90 days
	The company reported the previous year's revenue of 434.25 M. Net Loss for the year was (606.64 M) with loss before overhead, payroll, taxes, and interest of (370.78 M).
	Ultragenyx currently holds about 542.8 M in cash with (474.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.75.
	Over 98.0% of the company shares are owned by institutional investors
	Latest headline from gurufocus.com: Ultragenyx to Participate in Investor Conferences in December

Ultragenyx Quarterly Cash And Short Term Investments

621.61 Million

Ultragenyx uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Ultragenyx. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Ultragenyx's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	15th of February 2024 Upcoming Quarterly Report	View
	2nd of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	15th of February 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact Ultragenyx's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Ultragenyx's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2015-05-11	2015-03-31	-0.54	-0.63	-0.09	16
2020-10-27	2020-09-30	-1.26	-1.13	0.13	10
2015-11-09	2015-09-30	-0.87	-1.03	-0.16	18
2024-08-01	2024-06-30	-1.69	-1.52	0.17	10
2019-08-01	2019-06-30	-1.7	-1.89	-0.19	11
2015-08-13	2015-06-30	-0.63	-0.83	-0.2	31
2018-11-05	2018-09-30	-1.96	-1.74	0.22	11
2020-05-06	2020-03-31	-1.68	-1.91	-0.23	13

Know Ultragenyx's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Ultragenyx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ultragenyx backward and forwards among themselves. Ultragenyx's institutional investor refers to the entity that pools money to purchase Ultragenyx's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Rock Springs Capital Management Lp	2024-06-30	1.9 M
Millennium Management Llc	2024-06-30	1.9 M
Vestal Point Capital Lp	2024-06-30	1.8 M
Deutsche Bank Ag	2024-06-30	1.8 M
Baker Bros Advisors Lp	2024-09-30	1.6 M
Geode Capital Management, Llc	2024-09-30	1.6 M
Alliancebernstein L.p.	2024-06-30	1.5 M
Amvescap Plc.	2024-06-30	1.3 M
Alyeska Investment Group, L.p.	2024-09-30	1.2 M
Vanguard Group Inc	2024-09-30	9.9 M
Blackrock Inc	2024-06-30	5.6 M

Note, although Ultragenyx's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ultragenyx's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.44 B.

Market Cap

2.39 Billion

Ultragenyx's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	(0.47)	(0.50)
Return On Capital Employed	(0.47)	(0.49)
Return On Assets	(0.41)	(0.43)
Return On Equity	(2.20)	(2.09)

The company has Profit Margin (PM) of (1.07) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.95) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.95.

Determining Ultragenyx's profitability involves analyzing its financial statements and using various financial metrics to determine if Ultragenyx is a good buy. For example, gross profit margin measures Ultragenyx's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Ultragenyx's profitability and make more informed investment decisions.

Ultragenyx's Earnings Breakdown by Geography

Please note, the presentation of Ultragenyx's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ultragenyx's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ultragenyx's management manipulating its earnings.

Evaluate Ultragenyx's management efficiency

Ultragenyx has return on total asset (ROA) of (0.2412) % which means that it has lost $0.2412 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.8998) %, meaning that it created substantial loss on money invested by shareholders. Ultragenyx's management efficiency ratios could be used to measure how well Ultragenyx manages its routine affairs as well as how well it operates its assets and liabilities. As of November 28, 2024, Return On Tangible Assets is expected to decline to -0.5. In addition to that, Return On Capital Employed is expected to decline to -0.49. At present, Ultragenyx's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 20.3 M, whereas Other Current Assets are forecasted to decline to about 34.5 M.

	Last Reported	Projected for Next Year
Book Value Per Share	3.74	6.94
Tangible Book Value Per Share	0.88	0.84
Enterprise Value Over EBITDA	(6.48)	(6.80)
Price Book Value Ratio	12.77	16.58
Enterprise Value Multiple	(6.48)	(6.80)
Price Fair Value	12.77	16.58
Enterprise Value	3.3 B	2.3 B

The strategic initiatives led by Ultragenyx's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.

Beta

0.581

Basic technical analysis of Ultragenyx Stock

As of the 28th of November, Ultragenyx has the Variance of 3.67, risk adjusted performance of (0.1), and Coefficient Of Variation of (754.08). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Ultragenyx, as well as the relationship between them. Please validate Ultragenyx market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Ultragenyx is priced more or less accurately, providing market reflects its prevalent price of 48.13 per share. Given that Ultragenyx has information ratio of (0.20), we advise you to double-check Ultragenyx's current market performance to make sure the company can sustain itself at a future point.

Ultragenyx's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ultragenyx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ultragenyx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ultragenyx insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Howard Horn over a month ago Disposition of 7465 shares by Howard Horn of Ultragenyx at 52.76 subject to Rule 16b-3
		Sanders Corazon (corsee) D. over three months ago Disposition of 584 shares by Sanders Corazon D. of Ultragenyx at 40.98 subject to Rule 16b-3
		Suliman Shehnaaz over three months ago Acquisition by Suliman Shehnaaz of 9900 shares of Ultragenyx at 37.42 subject to Rule 16b-3
		Sanders Corazon (corsee) D. over three months ago Disposition of 1737 shares by Sanders Corazon D. of Ultragenyx at 41.1 subject to Rule 16b-3
		Fust Matthew K over six months ago Disposition of 2145 shares by Fust Matthew K of Ultragenyx at 50.85 subject to Rule 16b-3
		Theodore Huizenga over six months ago Acquisition by Theodore Huizenga of 2351 shares of Ultragenyx at 67.37 subject to Rule 16b-3
		Shehnaaz Suliman over a year ago Acquisition by Shehnaaz Suliman of 3860 shares of Ultragenyx subject to Rule 16b-3

Ultragenyx's Outstanding Corporate Bonds

Ultragenyx issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ultragenyx uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ultragenyx bonds can be classified according to their maturity, which is the date when Ultragenyx has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Boeing Co 2196 Corp Bond US097023DG73	View
	HSBC Holdings PLC Corp Bond US404280DR76	View
	MPLX LP 52 Corp Bond US55336VAL45	View

View All Ultragenyx Corporate Bonds

Understand Ultragenyx's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Ultragenyx's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	(0.1)
	Market Risk Adjusted Performance	(0.39)
	Mean Deviation	1.51
	Coefficient Of Variation	(754.08)
	Standard Deviation	1.92
	Variance	3.67
	Information Ratio	(0.20)
	Jensen Alpha	(0.34)
	Total Risk Alpha	(0.55)
	Treynor Ratio	(0.40)
	Maximum Drawdown	8.73
	Value At Risk	(3.20)
	Potential Upside	2.65
	Skewness	(0.64)
	Kurtosis	0.6518

	Risk Adjusted Performance	(0.1)
	Market Risk Adjusted Performance	(0.39)
	Mean Deviation	1.51
	Coefficient Of Variation	(754.08)
	Standard Deviation	1.92
	Variance	3.67
	Information Ratio	(0.20)
	Jensen Alpha	(0.34)
	Total Risk Alpha	(0.55)
	Treynor Ratio	(0.40)
	Maximum Drawdown	8.73
	Value At Risk	(3.20)
	Potential Upside	2.65
	Skewness	(0.64)
	Kurtosis	0.6518

Consider Ultragenyx's intraday indicators

Ultragenyx intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ultragenyx stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	0.0265
	Daily Balance Of Power	0.6016
	Rate Of Daily Change	1.02
	Day Median Price	47.6
	Day Typical Price	47.78
	Market Facilitation Index	1.28
	Price Action Indicator	0.92
	Period Momentum Indicator	0.77

Ultragenyx Corporate Filings

13A	14th of November 2024 An amended filing to the original Schedule 13G	View Verify
8K	12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about	View Verify
10Q	6th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations	View Verify
F4	11th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities	View Verify

Ultragenyx time-series forecasting models is one of many Ultragenyx's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ultragenyx's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Ultragenyx Stock media impact

Far too much social signal, news, headlines, and media speculation about Ultragenyx that are available to investors today. That information is available publicly through Ultragenyx media outlets and privately through word of mouth or via Ultragenyx internal channels. However, regardless of the origin, that massive amount of Ultragenyx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Ultragenyx news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ultragenyx relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ultragenyx's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ultragenyx alpha.

Ultragenyx Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Ultragenyx can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Ultragenyx Historical Investor Sentiment

Investor biases related to Ultragenyx's public news can be used to forecast risks associated with an investment in Ultragenyx. The trend in average sentiment can be used to explain how an investor holding Ultragenyx can time the market purely based on public headlines and social activities around Ultragenyx. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Ultragenyx's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ultragenyx and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ultragenyx news discussions. The higher the estimate score, the more favorable the investor's outlook on Ultragenyx.

Ultragenyx Corporate Management

Dennis Huang	Chief Technical Operations Officer and Sr. VP	Profile
Theodore Huizenga	Corporate VP	Profile
Arjun Natesan	Vice Research	Profile
Vimal Srivastava	Senior Management	Profile
Aaron Olsen	Senior Finance	Profile
Paul JD	Vice Property	Profile

When determining whether Ultragenyx is a strong investment it is important to analyze Ultragenyx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ultragenyx's future performance. For an informed investment choice regarding Ultragenyx Stock, refer to the following important reports: